A2-73 FOR TREATING ANGELMAN SYNDROME, WILLIAMS SYNDROME SMITH-MAGENIS SYNDROME AND MULTIPLE SCLEROSIS

• 收藏
• 分享

专利权人:

Anavex Life Sciences Corp.

发明人:

申请号：

EP22189051.0

公开号：

EP4104831A1

申请日:

2017.01.24

申请国别(地区):

EP

年份:

2022

代理人:

摘要：

This invention addresses tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73, AV2-73, or A2-73) in a method of treatment for neurodevelopmental disorders. Particular reference is made to the treatment of autism spectrum disorder, cerebral palsy, Rett syndrome, Angelman syndrome, Williams syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), childhood disintegrative disorder, and Smith-Magenis syndrome. Additional reference is made to multiple sclerosis

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/